BIO-key International, Inc. reported Q1 2025 revenue of $1.6M (-26.3% YoY), beat analyst consensus of $1.3M by $307.2K. Diluted EPS came in at $-0.16 (+50.0% YoY), beat the $-0.24 consensus by $0.08.
Trailing eight quarters through Q1 2025
Common questions about BIO-key International, Inc.'s Q1 2025 earnings report.
BIO-key International, Inc. (BKYI) reported Q1 2025 earnings on May 15, 2025 before market open.
BIO-key International, Inc. reported revenue of $1.6M and diluted EPS of $-0.16 for Q1 2025.
Revenue beat the consensus estimate of $1.3M by $307.2K. EPS beat the consensus estimate of $-0.24 by $0.08.
Compared to the same quarter a year prior, revenue declined 26.3% from $2.2M a year earlier and diluted EPS grew 50.0% from $-0.32.
You can read the 10-K periodic report (0001437749-25-012824) directly on SEC EDGAR. The filing index links above go to sec.gov.